Background
JIA, pain, auto-immune disease
DISEASE, REMISSION, JUVENILE IDIOPATHIC ARTHRITIS
Juvenile Idiopathic Arthritis (JIA) is the most common auto-immune disease in children, with an estimated prevalence of 33 per 100.000 children [In JIA, treatment to target (T2T) with clinical remission as a treatment goal has been widely recommended [The aim of this subanalysis is to compare pain scores over two years in three treatment strategies in non-systemic JIA patients who were treated to target aimed at inactive disease [